TransPharma Medical
Lod
About TransPharma Medical
TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug delivery technology. Their current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transdermal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $33.4M
- Funding stage: M&A
- Last round: Series C (Jul 2006)
- Website: transpharma-medical.com
- Phone: +972 8106185205
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/transpharma-medical-627120 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.